HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 293/2/F526    most recent 00052.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O'Connor, P. M. Articles by Cowley, A. W. Search for Related Content PubMed PubMed Citation Articles by O'Connor, P. M. Articles by Cowley, A. W., Jr.

Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V₂ receptor activation of the phosphoinositide pathway

Department of Physiology, The Medical College of Wisconsin, Milwaukee, Wisconsin

Submitted 1 February 2007 ; accepted in final form 14 May 2007

We previously reported that arginine vasopressin (AVP) stimulates the production of nitric oxide (NO) in inner medullary collecting duct (IMCD) via activation of V2 receptors (V2R) and the mobilization of intracellular Ca²⁺. The aim of this study was to determine the pathway(s) through which this response is mediated. IMCDs were dissected from male Sprague-Dawley rats and intracellular Ca²⁺ concentration ([Ca²⁺]_i) and NO production were measured using a fluorescence imaging system. AVP (100 nmol/l) produced a rapid increase [Ca²⁺]_i of 381 ± 78 nmol/l that was followed by a significant increase of NO production (166 ± 61%). The specific nonpeptide V2R antagonist OPC31260 (1 µM), but not the V1R antagonist OPC21268 (1 µM), inhibited the increase in [Ca²⁺]_i (up to 91 ± 5%) and abolished the NO response to AVP. Both the phospholipase C inhibitor U73112 [GenBank] (3 µM) and the inositol (1,4,5) tri-phosphate 3 receptor blocker 2-APB (75 µM) reduced the peak [Ca²⁺]_i response to AVP (by 65 ± 9 and 59 ± 15%, respectively) and abolished the NO response. Although forskolin (100 µM; an activator of adenylyl cyclase) elicited a moderate increase in [Ca²⁺]_i, neither preincubation with the adenylyl cyclase inhibitor 2'-5'-dideoxyadenosine (50 µM) nor the protein kinase A (PKA) inhibitor PKA_14-22 (100 µM) significantly inhibited peak [Ca²⁺]_i in response to AVP. IMCD [Ca²⁺]_i responses to AVP were reduced by 72 ± 8% when incubated in Ca²⁺-free media and could be completely abolished by preincubation with the Ca²⁺-ATPase inhibitor thapsigargin. We conclude that AVP-induced NO production in IMCD is dependent on V2R activation of the phosphoinositide pathway and the mobilization of Ca²⁺ from both intracellular and extracellular pools.

antidiuretic hormone; calcium; kidney; signal transduction; rats

This article has been cited by other articles:

				P. M. O'Connor, L. Lu, C. Schreck, and A. W. Cowley Jr. Enhanced amiloride-sensitive superoxide production in renal medullary thick ascending limb of Dahl salt-sensitive rats Am J Physiol Renal Physiol, September 1, 2008; 295(3): F726 - F733. [Abstract] [Full Text] [PDF]